Wednesday, 14 March 2012

Prescription Drug Sales-Blood Glucose Meters-Healthcare Business-Healthcare Division

Bayer sees healthcare business driving growth

FRANKFURT (Reuters) - German chemicals and drugs group Bayer expects higher profit margins and sales at its healthcare division over the next three years, where product launches are set to boost prescription drug sales by 16 percent. The healthcare division, which also makes non-prescription and animal health drugs, contrast agents and blood glucose meters, is aiming for sales of roughly 20 billion euros ($26.2 billion) in 2014, up from 17.2 billion euros last year, Germany's largest drugmaker said on Wednesday. ... read more..

No comments:

Post a Comment